Superworth

Kestra Medical Technologies KMTS

Medical - Instruments & Supplies, Healthcare
$29.81
+0.40%
Market cap
$1.8B
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
16.6×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$106.7M
+61% on a year ago
Net margin
n/m
outside −100% to 100%
Free cash flow yield
−6.9%

Kestra Medical Technologies trades at 16.6× sales. Its trailing earnings are negative, so it has no PE. Revenue was $106.7M over the last twelve months, up 61% on a year earlier.

Charts

Financials

Income statement for KMTS, by quarter
Income statementQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
$12.8M$14.7M$15.1M$17.2M$19.4M+52%$22.6M+53%$24.6M+63%$28.6M+66%$31M+60%
Cost of revenue$8.6M$8.9M$8.5M$9.6M$10.5M+23%$11.1M+26%$11.6M+36%$13M+35%$13.5M+28%
Gross profit$4.2M$5.8M$6.5M$7.6M$8.9M+111%$11.4M+96%$12.9M+97%$15.7M+106%$17.5M+98%
R&D$3.4M$3.5M$3.4M$5.4M$4M+18%$4.9M+39%$5M+48%$5.6M+5%$6.8M+70%
SG&A$19.2M$21.5M$23.8M$50.5M$33.7M+75%$38.3M+79%$42.7M+79%$49.4M−2%$48.4M+43%
−$18.4M−$19.1M−$20.6M−$48.2M−$28.9M+57%−$31.8M+66%−$34.8M+69%−$39.3M−18%−$37.7M+30%
Interest expense$1.9M$2.3M$1.8M$1.8M$1.9M+2%$1.9M−18%$1.9M+6%$1.8M+5%$1.9M+1%
Pre-tax income−$20.3M−$20.6M−$21.7M−$51M−$25.8M+27%−$32.8M+59%−$34.1M+57%−$38.6M−24%−$44M+71%
$7K$8K$18K$102K$33K+371%$34K+325%$35K+94%$192K+88%$50K+52%
Net income−$19.9M−$20.4M−$21.5M−$52.1M−$25.8M+30%−$32.8M+61%−$34.2M+59%−$38.8M−25%−$44.1M+71%
−$1.12−$1.19−$1.25−$1.41−$0.50−55%−$0.64−46%−$0.61−51%−$0.67−53%−$0.75+50%
19.9M19.9M19.9M39.2M51.3M+158%51.4M+158%55.8M+181%58.3M+49%58.6M+14%

EPS, diluted: Q4 FY25 and Q4 FY26: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY25 and Q4 FY26: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest Kestra Medical Technologies' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
KMTSKestra Medical Technologies$1.8Bn/mn/a16.6×+61%n/m
LMATLemaitre Vascular$1.9B28.5×42.0×7.1×+12%25.0%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
UFPTUFP Technologies$2.2B30.6×25.6×3.5×+7%11.4%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
STAAStaar Surgical$1.3B356×144×3.7×+51%1.1%
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
WRBYWarby Parker$2.9B341×359×3.2×+11%0.8%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
ATRCAtriCure$3B285×61.7×5.3×+14%1.9%
Peer median$1.6B34.8×49.5×2.7×+9%3.9%

More on Kestra Medical Technologies

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .